Med. praxi. 2012;9(4):179-182

OAB and urinary incontinence

MUDr.Eva Burešová, MUDr.Aleš Vidlář, doc.MUDr.Vladimír Študent, Ph.D.
Urologická klinika LF UP a FN Olomouc

Numerous papers address the issue of urinary incontinence. It is one of the most common lower urinary tract symptoms. Although urinary

incontinence is not a serious condition associated with high morbidity or mortality rates, it has a significant impact on the quality

of life of patients. The aim of the paper is to present an overview of the issue of urinary incontinence with a focus on OAB, ranging from

terminology to diagnosis to treatment options.

Keywords: overactive bladder, urinary incontinence, anticholinergic drugs, muscarinic receptors, botulinum toxin

Published: April 25, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Burešová E, Vidlář A, Študent V. OAB and urinary incontinence. Med. praxi. 2012;9(4):179-182.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Abrams P, CArdozo L, Fall M, et al. The standartisation of terminology of lower tract fuction: report from the standartisation sub-commitee of the International Continence Society. Neurol and Urodynamics 2002; 21(5): 1670-1678. Go to original source... Go to PubMed...
    2. Hunskaar S, Burgio K, Diokno A, et al. Epidemiology and history of urinary inkontinence.In: Abrams P, Cardozo L, Khoury S, et al. 2nd International Consultation on Incontinence. Plymouth: Health Publ. Ltd 2002: 165-201.
    3. Irwin DE, Milsom I, Hunskaar S, et al. Population-based surfy of urinary incontinece, overactive bladder and other Loir urinary tract symptoms in five contries; results of the EPIC study. Eur Urol 2006; 50: 1306-1314. Go to original source... Go to PubMed...
    4. Johnson T, Kincade J, Bernard S, et al. Self-care practise used by older men and women to manage urinary inkontinence: results from National Follow - up Servey on Self-Care and Aging. J Am Geriatr Society 2000; 48(4): 894-902. Go to original source... Go to PubMed...
    5. Moorthy P, Lapitan MC, Quek PL, Lim PH. Prevalence of overactive bladder in Asian men: an epidemiological surfy. BJU Int 2004; 93(4): 528-534. Go to original source... Go to PubMed...
    6. Digescu GA, Khullar V, Cardozo L, Salvatore S. Overactive bladder symptoms. Do we need urodynamics? Neurol Urodynamics 2003; 22(2): 105. Go to original source... Go to PubMed...
    7. Colli E, Artibani W, Goka J, Parazzini F, Wein AJ. Are urodynamic tests useful tools for the initial konservative management of non-neurogenic urinary inkontinence? A rewiev of the literature. Eur Urol 2003; 43(1): 63. Go to original source... Go to PubMed...
    8. Bermelmans BL, Kiemeney LA, Debruyne FM. Low dose oxybutinin for the treatment of urge inkontinence: good efficacyand few side effects. Eur Urol 2000; 37(6): 709. Go to original source... Go to PubMed...
    9. Viktrup L, Summers KH, Dennett SL. Clinical practice guidelines for the initial management of urinary inkontinence in women: a European-focused rewiev. BJU Int 2004; 94(Suppl 1): 14. Go to original source... Go to PubMed...
    10. Abrams P, Larson G, Chapel C, Wein AJ. Factors involved in the Access of antimuscarinic treatment. BJU Int 1999; 83(Suppl 2): 42. Go to original source... Go to PubMed...
    11. Bergmans L, Hendrikc H, de Brie R, et al. Conservative treatment of urge urinary inkontinence in women: a systematic rewiev of randomized clinical trails. BJU Int 2000; 85(2): 254-263. Go to original source... Go to PubMed...
    12. Castelden CM, George CF, REnwick AG, et al. Imipramine - a possible alternative to current therapy for urinary inkontinence in elderly. J Urol 1981; 125: 218-221. Go to original source... Go to PubMed...
    13. Cardozo LD, Rekers H, Tapp A, et al. Oestriol in treatment of postmenopauzal urgency: a multicentre study. Maturitas 1993; 18: 47-53. Go to original source... Go to PubMed...
    14. Arbatini W. Overactive bladder: new perspectives. Eur Urol 2002; Suppl 4(1): 1-30. Go to original source...
    15. Erdal E, Bartels F, Binscheck T, Erdmann G, Frevert J, Kistner A, Keller U, Wever J, Bigalke H. Processing of tetanus and botulinum A neurotoxins in isolated chromaffin cells. Naunyn Schmiedeberg´s Arch Pharmacol 1995; 351: 67-78. Go to original source... Go to PubMed...
    16. Schurch B, Stohrer M, Kramer G, et al. Botulinum A toxin for treating detrusor hyperreflexia in spinal cord injured patiens: a new alternative to anticholinergic drugs? Preliminary results. J Urol 2000; 164: 692-697. Go to original source... Go to PubMed...
    17. Reitz A, von Tobel J, Stöhrer M. European experience of 184 cases treated with botulinum - a toxin injections into detrusor muscle for neurogenic incontinence. Neurourol Urodyn 2002; 21: 427-428.

    Return to the content


    Medicine for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.